Pegylated Liposomal Doxorubicin Plus Ifosfamide for Advanced or Metastatic Soft-Tissue Sarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pegylated liposomal doxorubicin combined with ifosfamide for treating advanced or metastatic soft tissue sarcoma: a prospective, single-arm phase II study
Clin. Cancer Res 2022 Oct 14;[EPub Ahead of Print], X Liu, S Jiang, H Wang, X Wu, W Yan, Y Chen, Y Xu, C Wang, W Yao, J Wang, L Yu, J Miao, H Chen, J Xia, M Huang, X Zhang, Z LuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.